RisCView: October 2022
Monthly performance ranking of investment products.
Market Commentary: October 2022
Market Commentary: October 2022 Global Market Themes: Narrative of global slowing in place of interest rate hikes buoys risk assets Third quarter company earnings in line or better than expected, supporting equities Appointment of new prime minister provides...China Market Commentary: October 2022
China Market Commentary: October 2022 Here are this month’s highlights:The Hong Kong’s Hang Seng Index fell by 6.4% on the Monday after the new Politburo Standing Committee was announced at the Chinese Communist Party Congress. The Golden Dragon Index of US-listed...RisCura – SAVCA Private Equity Performance Report: South Africa Q1 2022
We are pleased to release the December 2021 edition of the RisCura – SAVCA South African Private Equity Performance Report. This report tracks the performance of a representative basket of South African private equity funds and is published quarterly. The...RisCView: September 2022
Monthly performance ranking of investment products.
Market Commentary: September 2022
Market Commentary: September 2022 Global Market Themes: Equity and fixed-income markets experience more pain in September Bank of England abruptly reverses course on Quantitative Tightening Japanese Yen sees first currency intervention in 24 years US Federal...China Market Commentary: September 2022
China Market Commentary: September 2022 Here are this month’s highlights:The bulk of the manager cohort was underweight to China compared to the neutral benchmark index weight.The median global emerging market manager has also come to realise the importance of...RisCView: August 2022
Monthly performance ranking of investment products.
RisCView: July 2022
Monthly performance ranking of investment products.